Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
शेयरों में रैंक #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
शेयर मूल्य
$0.089
अंतिम समन्वयन: 2026-08-17
मार्केट कैप
$15.36M
बदलाव (1 दिन)
50.59%
बदलाव (1 वर्ष)
111.85%
देश
US
व्यापार Inhibitor Therapeutics, Inc. (INTI)

श्रेणी

Inhibitor Therapeutics, Inc. (INTI) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.08 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $13.64 (2003-09-01 को)
Inhibitor Therapeutics, Inc. के स्टॉक मूल्य का इतिहास 2003 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 36.71%
2025 -32.43%
2024 -25.17%
2023 28.96%
2022 -48.45%
2021 273.68%
2020 -20.00%
2019 -55.15%
2018 -60.33%
2017 -30.61%
2016 198.81%
2015 -0.18%
2014 51.76%
2013 -99.13%
2004 -21.95%
2003 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE